XTRA:AFXMedical Equipment
A Look At Carl Zeiss Meditec (XTRA:AFX) Valuation After Revenue Guidance Cut And Quarterly Net Loss
Carl Zeiss Meditec (XTRA:AFX) cut its revenue outlook after a weak start to the year, citing softer sales expectations in the US and China as well as pressure from China’s new volume based procurement process.
See our latest analysis for Carl Zeiss Meditec.
The revenue guidance cut and first quarter net loss arrived after a sharp reset in sentiment, with a 30 day share price return of 32% decline and a 1 year total shareholder return of 50.65% decline, signalling fading momentum despite...